Promis Neurosciences (PMN)
(Delayed Data from NSDQ)
$1.37 USD
+0.07 (5.09%)
Updated Aug 30, 2024 03:41 PM ET
After-Market: $1.34 -0.03 (-1.92%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PMN 1.37 +0.07(5.09%)
Will PMN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PMN based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for PMN
ProMIS Neurosciences files to sell 56.51M common shares for holders
Around $2M Bet On This Health Care Stock? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
ProMIS Neurosciences GAAP EPS of -$0.13